CTLT
Catalent Inc
Price:  
63.07 
USD
Volume:  
1,151,096.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Catalent Relative Valuation

-156.8%
Upside

As of 2024-12-14, the Relative Valuation of Catalent Inc (CTLT) is (35.84) USD. This relative valuation is based on P/E multiples. With the latest stock price at 63.07 USD, the upside of Catalent Inc based on Relative Valuation is -156.8%.

The range of the Relative Valuation is (37.50) - (44.01) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 16.5x - 23.9x 18.0x
Forward P/E multiples 12.9x - 19.3x 13.5x
Fair Price (37.50) - (44.01) (35.84)
Upside -159.5% - -169.8% -156.8%
63.07 USD
Stock Price
(35.84) USD
Fair Price

Catalent Relative Valuation - Historical P/E Data

Date P/E
2024-12-13 -27.72
2024-12-12 -27.71
2024-12-11 -27.79
2024-12-10 -27.35
2024-12-09 -27.41
2024-12-06 -27.17
2024-12-05 -27.30
2024-12-04 -27.18
2024-12-03 -27.12
2024-12-02 -27.00
2024-11-29 -26.86
2024-11-27 -26.81
2024-11-26 -26.70
2024-11-25 -26.94
2024-11-22 -26.80
2024-11-21 -26.22
2024-11-20 -25.93
2024-11-19 -25.88
2024-11-18 -25.83
2024-11-15 -25.97
2024-11-14 -25.89
2024-11-13 -26.00
2024-11-12 -26.04
2024-11-11 -26.13
2024-11-08 -26.11
2024-11-07 -26.33
2024-11-06 -26.35
2024-11-05 -25.70
2024-11-04 -25.79
2024-11-01 -25.81
2024-10-31 -25.75
2024-10-30 -25.92
2024-10-29 -25.78
2024-10-28 -25.85
2024-10-25 -25.97
2024-10-24 -26.15
2024-10-23 -26.11
2024-10-22 -26.33
2024-10-21 -26.45
2024-10-18 -26.50
2024-10-17 -26.41
2024-10-16 -26.49
2024-10-15 -26.66
2024-10-14 -26.66
2024-10-11 -26.57
2024-10-10 -26.68
2024-10-09 -26.79
2024-10-08 -26.70
2024-10-07 -26.64
2024-10-04 -26.63